Umeå University
umu.seTotal trials
263
Active
67
Phase 3
10
Total enrollment
2,597,409
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Betamethason Sodium Phosphate | — | — | — | — | — | 1 | |
| 10% glucose solution | — | — | — | — | — | 1 | |
| Control | — | — | — | — | — | 1 | |
| antibiotic loaded bone cement (gentamicin+clindamycin) COPAL G+C (Heraeus). | — | — | — | — | — | 1 | |
| antibiotic loaded bone cement (gentamicin) Paladins R+G (Heraeus) or Refobacin (Biomet). | — | — | — | — | — | 1 |
Next readouts
- 2025-06-20
- 2026-01-31
- 2029-12-31
Top conditions
- Healthy8
- Stroke7
- Postoperative Complications6
- Obesity6
- Depression6
- Accidental Falls4
- Anesthesia4
- Heart Failure4
Frequently asked questions about Umeå University
- How many clinical trials does Umeå University have on ClinicalTrials.gov?
- Umeå University is listed as the lead sponsor on 263 clinical trials in ClinicalTrials.gov, 67 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Umeå University's trials are in Phase 3?
- 10 of Umeå University's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Umeå University focus on?
- Umeå University's most-studied conditions on ClinicalTrials.gov are Healthy, Stroke, Postoperative Complications, Obesity, Depression.
- When are Umeå University's next clinical trial readouts?
- Umeå University has 3 upcoming primary-completion readouts tracked here; the soonest is “Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy”, expected around 2025-06-20.